Stokes Frank
- SEC CIK
- 0001782815
In the past year, 5 open-market sale filings worth $1.46M and no purchases.
Current role at each company
- CSTL Castle Biosciences IncChief Financial Officeras of Aug 18, 2026
- XGN Exagen Inc.Directoras of Jun 22, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.46M
- 5 filings
- Net
- −$1.46M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Stokes Frank as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CSTL Castle Biosciences Inc
Chief Financial Officer8 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 2026 (view filing)4:10 PM ET | Aug 14 | 4 days | Stokes FrankChief Financial Officer | SSale | −24.9K | $29.77 | −$741.5K | −41.5%35.2K after | |
| Mar 9, 2026 (view filing) | Mar 5 | 4 days | Stokes FrankChief Financial Officer | SSale | −6.00K | $27.98 | −$167.9K | −9.1%60.1K after | 10b5-1 |
| Mar 5, 2026 (view filing) | Mar 3 | 2 days | Stokes FrankChief Financial Officer | SSale | −7.00K | $27.44 | −$192.1K | −11.8%52.5K after | 2 lots10b5-1 |
| Dec 15, 2025 (view filing) | Dec 11 | 4 days | Stokes FrankChief Financial Officer | SSale | −4.50K | $37.45 | −$168.4K | −8.2%50.3K after | |
| Nov 13, 2025 (view filing) | Nov 11 | 2 days | Stokes FrankChief Financial Officer | SSale | −5.39K | $35.08 | −$189.0K | −11.1%43.3K after | 10b5-1 |
| Feb 24, 2025 (view filing) | Feb 20 | 4 days | Stokes FrankChief Financial Officer | SSale | −8.05K | $26.70 | −$214.8K | −18.6%35.3K after | 10b5-1 |
| Nov 19, 2024 (view filing) | Nov 15 | 4 days | Stokes FrankChief Financial Officer | SSale | −6.92K | $29.93 | −$207.2K | −18.3%30.8K after | 2 lots10b5-1 |
| Aug 13, 2024 (view filing) | Aug 7 | 6 daysLate | Stokes FrankChief Financial Officer | SSale | −10.0K | $25.70 | −$257.0K | −24.5%30.8K after | 2 lots10b5-1 |